Enhanced fetal γ-globin synthesis alleviates symptoms of β-globinopathies such as sickle cell disease and β-thalassemia, but current γ-globin–inducing drugs offer limited beneficial effects. We show here that lysine-specific demethylase 1 (LSD1) inhibition by RNAi in human erythroid cells or by the monoamine oxidase inhibitor tranylcypromine in human erythroid cells or β-type globin–transgenic mice enhances γ-globin expression. LSD1 is thus a promising therapeutic target for γ-globin induction, and tranylcypromine may serve as a lead compound for the development of a new γ-globin inducer.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Gene Expression Omnibus
Testa, U. Ann. Hematol. 88, 505–528 (2009).
Tanabe, O. et al. EMBO J. 21, 3434–3442 (2002).
Tanabe, O. et al. EMBO J. 26, 2295–2306 (2007).
Cui, S. et al. Mol. Cell Biol. 31, 3298–3311 (2011).
Shi, Y. et al. Cell 119, 941–953 (2004).
Hu, X. et al. Proc. Natl. Acad. Sci. USA 106, 10141–10146 (2009).
Saleque, S., Kim, J., Rooke, H.M. & Orkin, S.H. Mol. Cell 27, 562–572 (2007).
Lee, M.G., Wynder, C., Schmidt, D.M., McCafferty, D.G. & Shiekhattar, R. Chem. Biol. 13, 563–567 (2006).
Mallinger, A.G. & Smith, E. Psychopharmacol. Bull. 27, 493–502 (1991).
Wang, J. et al. Nat. Genet. 41, 125–129 (2009).
Moutouh-de Parseval, L.A. et al. J. Clin. Invest. 118, 248–258 (2008).
Banzon, V. et al. Exp. Hematol. 39, 26–36. e1 (2011).
Sankaran, V.G. et al. Nature 460, 1093–1097 (2009).
Buller, A.M., Elford, H.L., DuBois, C.C., Meyer, J. & Lloyd, J.A. Blood Cells Mol. Dis. 25, 255–269 (1999).
Xu, J. et al. Science 334, 993–996 (2011).
Menzel, S. et al. Nat. Genet. 39, 1197–1199 (2007).
Wilber, A., Nienhuis, A.W. & Persons, D.A. Blood 117, 3945–3953 (2011).
Frieling, H. & Bleich, S. Eur. Arch. Psychiatry Clin. Neurosci. 256, 268–273 (2006).
Sprüssel, A. et al. Leukemia 26, 2039–2051 (2012).
Eyer, F., Jetzinger, E., Pfab, R. & Zilker, T. Clin. Toxicol. (Phila.) 46, 261–263 (2008).
Giarratana, M.C. et al. Nat. Biotechnol. 23, 69–74 (2005).
Irizarry, R.A. et al. Biostatistics 4, 249–264 (2003).
This work was supported by US National Institutes of Health grants DK086956 (to O.T. and J.D.E.) and HL24415 (to J.D.E.) and an American Heart Association postdoctoral fellowship to L.S. We thank D. Giacherio and D. Harro for hemoglobin HPLC analysis; C. Yu, A.D. Campbell, K.C. Lim, T. Hosoya, B. Godfrey and M. Sierant for discussions, comments and technical assistance; and D. Lavelle and J. DeSimone for discussions regarding the inductive properties of decitabine. Lentiviruses were produced by the University of Michigan Vector Core. Microarray analysis was performed at the University of Michigan Microarray Core.
The authors declare no competing financial interests.
About this article
Cite this article
Shi, L., Cui, S., Engel, J. et al. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction. Nat Med 19, 291–294 (2013). https://doi.org/10.1038/nm.3101
Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation
European Journal of Pharmacology (2021)
UNC0638 induces high levels of fetal hemoglobin expression in β-thalassemia/HbE erythroid progenitor cells
Annals of Hematology (2020)
Journal of Clinical Medicine (2020)
High‐level induction of fetal haemoglobin by pomalidomide in β‐thalassaemia/HbE erythroid progenitor cells
British Journal of Haematology (2020)
Seminars in Hematology (2020)